NCT02057731View on ClinicalTrials.gov

Study of Glycogen Storage Disease Expression in Carriers

CompletedOBSERVATIONAL
Enrollment

114

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

July 31, 2016

Study Completion Date

July 31, 2016

Conditions
Glycogen Storage Disease
Interventions
GENETIC

Glycogen Storage Disease markers

Blood and urine tests will be performed on all groups to measure markers of GSD. A saliva DNA test will be used to determine the specific mutation the carrier has or to ensure noncarrier status. A questionnaire will also be filled out.

Trial Locations (1)

32608

University of Florida, Gainesville

All Listed Sponsors
lead

University of Florida

OTHER

NCT02057731 - Study of Glycogen Storage Disease Expression in Carriers | Biotech Hunter | Biotech Hunter